Company intelligence / Profile preview

Beghin Meiji

Ownership: Private
Development stage: Other

Overview

Beghin Meiji is a joint venture between Tereos Starch & Sweeteners Europe and Japan's Meiji Group. It focuses on the production of functional food ingredients, notably fructooligosaccharides such as Mayoligo®, for human, animal, and pet nutrition. The company also has activities related to bio-based cleaning agents using proprietary bacterial strains but does not operate in drug development or clinical research.

Industry: Food & Nutrition

Partnerships

Tereos Starch & Sweeteners Europe (joint venture partner)Samyang Corp. (South Korea) – production partnership for Mayoligo® in Asia/OceaniaIngredion – North American production partner for Mayoligo®

Beyond the preview

Go deeper on Beghin Meiji.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beghin Meiji.

Explore the full profile